<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4021">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04840953</url>
  </required_header>
  <id_info>
    <org_study_id>ENFIVAC</org_study_id>
    <nct_id>NCT04840953</nct_id>
  </id_info>
  <brief_title>Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients</brief_title>
  <official_title>Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background Numerous surgicals treatments have been described for the massive subcutaneous&#xD;
      emphysema; however, some of these techniques cannot be carried out in a critical care unit&#xD;
      and they are related with high morbidity and exposure in positive SARS COV-2 patients. More&#xD;
      effective, less invasive and isolated procedures should be implemented.&#xD;
&#xD;
      Technique Negative pressure therapy (NPT) that can allow effective solving of massive&#xD;
      subcutaneous emphysema in a short period (5 days) with a minimally invasive approach at the&#xD;
      bedside in Covid-19 or non infected critical patients.&#xD;
&#xD;
      Conclusion NPT is an effective and low invasive strategy for the management of EES in&#xD;
      critical patients with high risk of mortality.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">February 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>Resolution time of emphysema with negative pressure therapy</measure>
    <time_frame>Days</time_frame>
    <description>Days</description>
  </primary_outcome>
  <enrollment type="Actual">2</enrollment>
  <condition>Subcutaneous Emphysema</condition>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vçac</intervention_name>
    <description>VAC THERAPY vs SURGICAL DREINAGE</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subcutaneous emphysema that compromises ventilation with or not SARS COV2 infection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subcutaneous emphysema that compromises ventilation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Declined Therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital General Universitario de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>03203</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 8, 2021</study_first_submitted>
  <study_first_submitted_qc>April 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2021</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana</investigator_affiliation>
    <investigator_full_name>Luis Sánchez Guillen</investigator_full_name>
    <investigator_title>Colorrectal Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Emphysema</mesh_term>
    <mesh_term>Emphysema</mesh_term>
    <mesh_term>Subcutaneous Emphysema</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

